SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MGI Pharma MOGN New patents, anti cancer
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (1486)3/17/2004 6:49:09 AM
From: Icebrg  Read Replies (1) of 1826
 
Aloxi Injection 2004 Sales Results Expected to Exceed Previous Guidance
Wednesday March 17, 6:45 am ET

MINNEAPOLIS--(BUSINESS WIRE)--March 17, 2004--MGI PHARMA, INC. (Nasdaq:MOGN - News) today announced that it expects sales of Aloxi(TM) injection for the first quarter of 2004 to exceed previous guidance of $12 million. MGI PHARMA now anticipates sales of Aloxi injection to be in the range of $15 million to $17 million for the first quarter. Recent trends indicate that 2004 annual sales of Aloxi injection could exceed prior guidance and range from $100 million to $110 million.

"More than 125,000 patient treatments with Aloxi injection have occurred since its launch in September 2003," said Lonnie Moulder, president and chief executive officer of MGI PHARMA. "We are very pleased that the launch of Aloxi is off to a great start, and believe that this sales performance positions us well to continue executing on our business development initiatives."

MGI PHARMA plans to issue its first quarter 2004 financial results news release, including updated annual 2004 guidance, before the market opens on Wednesday, April 14, 2004. Following this news release, the Company will broadcast its first quarter 2004 financial results conference call live over the Internet on Wednesday, April 14, 2004 at 1:00 p.m. Eastern Time. All interested parties are welcome to access the webcast via the Company's Web site at www.mgipharma.com.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News